Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Collaborative networks between Spain and Latin America regarding multiple sclerosis].
Prediction of MS disability by multimodal evoked potentials: Investigation during relapse or in the relapse-free interval?
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data.
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.
Optic Nerve Sheath Meningioma Masquerading as Optic Neuritis.
Patch-Based Segmentation with Spatial Consistency: Application to MS Lesions in Brain MRI.
Perceived Impact of a Self-Management Program for Fatigue in Multiple Sclerosis: A Qualitative Study.
Gavin Giovannoni on why time matters in multiple sclerosis.
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.
Walking execution is not affected by divided attention in patients with multiple sclerosis with no disability, but there is a motor planning impairment.
Advances in the management of multiple sclerosis spasticity: recent clinical trials.
The conundrum of interferon-β non-responsiveness in relapsing-remitting multiple sclerosis.
T cell chemokine receptor patterns as pathogenic signatures in autoimmunity.
Challenging AQP4 druggability for NMO-IgG antibody binding using molecular dynamics and molecular interaction fields.
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Validation of Social Media Analysis for Outcomes Research: Identification of Drivers of Switches between oral and Injectable Therapies for Multiple Sclerosis.
Comment on the Paper by Esen et al. Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis.
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.

Pages